Transforming imaging data into actionable predictions

We design pioneering tools that unlock imaging data to improve patient outcomes.
From clinical research to personalized care.
Healthcare providers, biopharma companies, research and academic institutions and RWE specialists partner with Quibim to power up the imaging portion of their business, accelerating the arrival of precision medicine.

Our unique multi-scale ways of seeing problems can guide decision-making at every stage in the drug development program. Quibim can reveal a full suite of novel imaging biomarkers from existing and new patient datasets to enhance the power of multi-omics: deeply analyze disease mechanisms, find the right candidates for clinical studies, stratify patients with different risks, predict patient outcomes and drug response and monitor treatment progress using a tissue-agnostic approach.

As a global leader in medical imaging analysis and processing, our best-in-class software medical devices and solutions extract objective and highly accurate information versus traditional methods, using the latest AI technology. We have advanced image harmonization techniques generating a standardized image quality that minimizes variability across equipment manufacturers and acquisition protocols. Quibim has access to large scale databases and can analyze any image modality and any tissue from thousands of consecutive patients.

*Please note that we do not analyze pathological images.